2010
DOI: 10.1007/s11239-010-0474-4
|View full text |Cite
|
Sign up to set email alerts
|

Prothrombotic markers in asymptomatic dyslipidemic subjects

Abstract: The aim of this study was to evaluate the plasma levels of prothrombotic markers--von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (t-PA)--in asymptomatic subjects with dyslipidemia. Asymptomatic subjects with dyslipidemia and their relatives (n = 234) were assessed for lipids and prothrombotic markers. Individuals were divided into four dyslipidemic phenotypes (DLP) according to apolipoprotein B (apoB) and triglycerides (TG): DLP1 (n = 58, apoB < 1.2 g/l and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 81 publications
0
7
1
Order By: Relevance
“…PAI-1 was suggested to be a predictor for cardiovascular disease [30]. However, associations between PAI-1 and CIMT were not consistent in different studies [31, 32]. We tested PAI-1 in the present study but found no associations between PAI-1 and CIMT indexes.…”
Section: Discussioncontrasting
confidence: 51%
“…PAI-1 was suggested to be a predictor for cardiovascular disease [30]. However, associations between PAI-1 and CIMT were not consistent in different studies [31, 32]. We tested PAI-1 in the present study but found no associations between PAI-1 and CIMT indexes.…”
Section: Discussioncontrasting
confidence: 51%
“…First, increased CVR may signify a broader general risk for common diseases, including non-CV-related illnesses, since higher CVR can indicate frailer individuals. This may be due to the fact that CVR is often associated with pro-inflammatory or pro-thrombotic states, 19,20 which are also known to contribute to a number of non-CV diseases (e.g. respiratory diseases, musculoskeletal pathology, or infectious diseases).…”
Section: Discussionmentioning
confidence: 99%
“…These markers of endothelial damage were used because we previously found significant differences in their levels between individual DLPs (ref. 18,19 ).…”
Section: Biochemical Analysesmentioning
confidence: 99%